BrainStorm Cell Therapeutics Inc. and Rutgers University Join Forces to Identify a Cure for Spinal Cord Injuries via Stem-Cell Research

NEW BRUNSWICK, N.J. & NEW YORK & PETACH TIKVAH, Israel--(BUSINESS WIRE)--BrainStorm Cell Therapeutics Inc. (OTCBB:BCLI), a leading developer of adult stem cell technologies and therapeutics, is pleased to announce that the Company has expanded its collaboration with Rutgers University in an effort to cure spinal cord injuries through BrainStorm’s cutting-edge adult stem cell research. The Spinal Cord Injury Project is the first focus of the W. M. Keck Center for Collaborative Neuroscience at Rutgers University.